Trial intelligence / Profile preview

Sertraline for depression in hospitalized coronary heart disease patients

ChiCTR-ONC-12002609Phase 4Completed

Sponsor
Beijing An Zhen Hospital
Start
Sep 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of sertraline in major depressive disorder (MDD), sponsored by Beijing An Zhen Hospital. Primary endpoint: Hamilton Depression Scale (HAMD-17). Started Sep 2010; status: completed.

02

Drugs

sertraline
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on ChiCTR-ONC-12002609.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-ONC-12002609.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call